HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

1.1%

4.0%

8.0%

15.4%

13.8%

38.2%

32.5%

10y

16.1%

all

13.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 414 1.1%

318

434

Company Overview

Sales

1,822 Cr

Growth: -1.6%

Profit after Tax

74.6 Cr

Growth: 1.5%

Small Cap

5,110 Cr

P/E: 68.6x

Industry P/E: 29.6x

Fundamentals

Sales (Cr)	₹ 1,822
Growth	-1.6%
EBITDA	16.4%
P/S	2.8x
Dividend	0.3%
P/E	68.6x
Book Value	₹ 99.6
PEG Ratio	-42.1x
ROE	6.2%
P/B	4.2x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (10 Indices) view more

Investors (60)

himalaya...

internat...

ritu.aru...

Followers (6)

mike2

nitin29

vishal48